
Kybella for double chin treatment is an FDA-approved injectable that uses synthetic deoxycholic acid to destroy fat cells beneath the chin, reducing submental fullness without surgery. A licensed medical professional administers Kybella across a series of sessions rather than a single visit, following a clinically guided protocol with the number and spacing set by an individualized treatment plan.
Kybella removes fat through a different mechanism than liposuction’s surgical extraction or CoolSculpting’s controlled cooling, though all three address the same submental fat concern.
Kybella is a customized injectable treatment offered at Anne Therese Aesthetic Medicine as part of an individualized treatment plan built around an individual’s chin and neck anatomy. Kybella contains synthetic deoxycholic acid, a compound that breaks down fat cells on contact.
A licensed medical professional injects it directly into the submental area. That area is the pocket of fat between the chin and neck that produces the visual effect commonly called a double chin.
Deoxycholic acid occurs naturally in the body, where it helps break down fat during digestion. The synthetic version used in Kybella damages the outer membrane of fat cells in the treated area, and the body clears those damaged cells over the following weeks.
As the fat cells are removed, the tissue beneath the chin loses volume, which changes the contour along the jawline.
Deoxycholic acid destroys fat cells by breaking down their outer membrane, triggering a process called adipocytolysis that permanently removes those cells from the treatment area. Once a fat cell’s membrane is compromised, it can no longer store fat, and the body’s lymphatic system clears the remnants over time.
That permanence is limited to the specific cells destroyed, not to a lifetime state of the chin area. Swelling in the days after treatment reflects both the injection itself and this ongoing clearance process.
A Kybella treatment session follows a multi-step process, outlined below:
The number of Kybella sessions varies by patient. A licensed medical professional sets that number as part of an individualized treatment plan. The plan is based on the amount of submental fat and how the area responds to each round of injections.
Kybella is generally administered across multiple sessions rather than in a single visit. Fat cell destruction is gradual, and the treated area needs time to recover between rounds.
Spacing between sessions allows swelling from the prior treatment to resolve before the next round of deoxycholic acid is introduced. This lets the licensed medical professional assess progress before adjusting the plan.
Destroyed fat cells clear from the treated area gradually, so visible changes emerge over multiple weeks rather than immediately after the injections. The body needs time to process and remove the damaged cells, and that pace sets the timeline for each session’s results.
Swelling from the treatment itself can also mask early changes in the area. A licensed medical professional typically waits until that swelling has resolved before evaluating the result and determining whether additional sessions are needed.
Kybella permanently destroys the fat cells it treats. Deoxycholic acid breaks down the cell membrane in a way the body cannot reverse or regenerate in that specific population of cells. This permanence applies to the treated cells themselves, not to the chin’s overall appearance for the rest of a patient’s life.
Remaining or new fat cells in the area can still expand with future weight gain. That means submental fullness can return through a mechanism separate from the cells Kybella already destroyed.
Kybella, liposuction, and CoolSculpting all reduce submental fat but differ in how they remove or destroy it: injectable cell destruction, surgical excision, or controlled cooling, summarized in the table below.
Each comparison is broken down in more detail below.
Dissolving fat with an injectable compound is a different process than removing it surgically through a cannula, though both target the same submental fat.
Liposuction involves an incision and direct extraction, so it typically requires anesthesia and incision-based recovery. Kybella’s injectable approach avoids incisions but works through a gradual clearance process across multiple sessions instead of an immediate volume reduction.
Chemical injection and controlled cooling destroy submental fat through different mechanisms, though neither Kybella nor CoolSculpting requires surgery.
CoolSculpting uses an external applicator to cool tissue to a temperature that damages fat cells, without any needle injections. Kybella introduces deoxycholic acid directly into the tissue through a series of injections.
The lymphatic system gradually clears the destroyed cells from both treatments, so visible contour changes take weeks to appear rather than showing up right away.
A reasonable candidate for Kybella has moderate submental fat, stable body weight, and skin with enough elasticity to adapt as fat volume decreases beneath the chin. A licensed medical professional evaluates these factors during a consultation. The amount and distribution of submental fat, along with the skin’s ability to retract, affect whether Kybella is an appropriate option.
Patients with significant skin laxity or a larger volume of excess fat may be better suited to a surgical option. Kybella is designed to reduce fat volume through a series of injections, not to remove larger amounts of tissue at once.
Evaluating candidacy is part of the broader medical oversight built into every treatment plan at the practice. Anne Therese Aesthetic Medicine was founded by Dr. Anne Therese Stubbs, MD, a board-certified physician. She serves on the faculty boards of ZO Skin Health and Galderma and trains physicians nationally in facial injection technique.
Kybella commonly causes swelling, bruising, numbness, and firmness in the treated area, all of which reflect the tissue’s response to deoxycholic acid rather than a treatment complication. Swelling is typically most noticeable in the days immediately following an injection and subsides gradually as the destroyed fat cells clear the area. Numbness in the chin and neck can also occur, since the injections affect nerve endings near the treatment site.
A licensed medical professional reviews aftercare guidance for each individual, since the intensity and duration of these effects vary by patient.
Jawline definition improves after Kybella by changing the visual relationship between the chin, jaw, and neck as submental fat volume decreases, not because the treatment reshapes the jaw itself.
Submental fat sits below the jawline and blurs the transition between the chin and neck. As deoxycholic acid destroys fat cells in that pocket, tissue volume decreases. The underlying bone and muscle structure of the jaw becomes more visible from the front and side.
The resulting contour change comes entirely from the loss of fat volume beneath the jaw, not from any direct effect on the jaw or chin bone.
Yes, mildly for most patients. A brief sting or burning sensation is common as deoxycholic acid is injected, though a topical or local anesthetic applied beforehand limits discomfort during the session. Any burning or tightness that follows typically reflects the compound reaching the treated fat cells, not a sign of a problem.
No. Kybella is FDA-approved specifically for reducing fat beneath the chin, not for fat reduction in other areas of the body. A licensed medical professional evaluates which treatment options fit a different area of concern.
Yes, depending on the individualized treatment plan. A licensed medical professional builds that plan around an individual’s goals and treatment history. This decision is made during a consultation rather than following a standard combination protocol.
Beyond skin laxity and excess fat volume, active skin conditions or irritation at the injection site can affect whether Kybella is appropriate at a given time. A licensed medical professional reviews these factors during a consultation before starting an individualized treatment plan.
Kybella’s value comes from its mechanism, not just its non-surgical positioning: destroying targeted fat cells beneath the chin creates a lasting change in that tissue. Overall jawline definition still depends on individual anatomy, weight stability, and skin elasticity. A licensed medical professional can determine whether Kybella fits an individualized treatment plan based on submental fat volume and candidacy factors specific to each patient.
Ready to find out whether Kybella fits your goals for a sharper jawline? Schedule a consultation with Anne Therese Aesthetic Medicine.